Skip to main content

Older adults

Sulfonyureas

05-05-2021 | Older adults | News

Overly tight glucose control in older adults linked to country income

Older people with type 2 diabetes are more likely to receive inappropriately intensive glucose-lowering treatment if they live in high- versus middle income countries, show data from the global DISCOVER study.

01-03-2021 | Older adults | News

Sulfonylureas, insulin linked to increased hypoglycemia risk in older people with type 2 diabetes

Older individuals with type 2 diabetes and low glycated hemoglobin receiving treatment with a sulfonylurea or insulin have an increased risk for severe hypoglycemia, but there is no clear indication of an increased mortality risk, suggest UK study results.

24-11-2020 | Older adults | News

Age has no impact on CV outcomes with linagliptin vs glimepiride

Cardiovascular event rates do not differ significantly among people with type 2 diabetes treated with linagliptin or glimepiride regardless of age, but those who receive linagliptin have lower risks for falls and hypoglycemia, CAROLINA trial data show.

02-08-2018 | Older adults | News

More evidence for harm of intensive diabetes treatment in older patients

Research shows an increased mortality risk associated with the use of intensive antidiabetes treatments in older patients with type 2 diabetes.

Pill in hand (symbolic image with model)

13-02-2018 | Older adults | Editorial | Article

Does setting treatment targets risk the overtreatment of type 2 diabetes in older patients?

The drive to achieve lower HbA1c targets in older patients is not without concern or risk. Our UK Board address concerns highlighted by recent trials and discuss whether current guidelines do enough to mitigate the risks of overtreatment.

28-09-2017 | Hypoglycemia | News

Ambiguous symptoms may disguise hypoglycemia in elderly patients

Research suggests that older diabetes patients, particularly those using insulin, often have nonspecific symptoms of hypoglycemia that are overlooked by healthcare providers.